Health SynuSight, ABLi, and XingImaging Launch Collaboration for Parkinson’s Trials SynuSight Biotech, ABLi Therapeutics, and XingImaging have formed a strategic collaboration aimed at integrating alpha-synuclein PET imaging into clinical trials for evaluating the efficacy... Editorial6 days ago